Reacting to news of a pharmaceuticals deal with the US, William Bain, Head of Trade Policy at the BCC, said:

“The original trade deal, agreed with the US in May, promised preferential outcomes on pharmaceuticals tariffs for the UK. We are pleased to see this has now been delivered, with the confirmation that these exports to the US will be tariff free.

“Pharmaceuticals make up a fifth of all UK exports to the US by value, and the UK now has a deal which few others have achieved, giving us a distinct advantage.

“This deal is a real win. It will promote exports, boost investment, and enhance UK competitiveness as a production and innovation base for world-leading medicines and treatments.”